Harvard

Irene Ghobrial, MD, will receive the William Dameshek Prize at this year’s ASH Annual Meeting & Exposition.

A dramatic rise in global incidence of early-onset cancers over the past 30 years may be related in part to increased exposure to risk factors at a young age, according to study results published in Nature Reviews Clinical Oncology,

Prostate cancer clinical trials included significant underrepresentation of Asian, Black and Hispanic men based on incidence of the disease among these groups, results of meta-analysis published in JAMA Oncology showed.

Endocrine therapies have revolutionized the field of breast cancer, with significant improvements in survival outcomes among patients with hormone receptor-positive disease.

Women who adhered more to a plant-based Portfolio diet lowered their risk for developing type 2 diabetes, according to findings from the Women’s Health Initiative published in Diabetes Care.

In this video, Ann Mullally, MD, discussed her presentation investigating the use of therapeutic antibodies to target mutant calreticulin in myeloproliferative neoplasms.

WASHINGTON — An accelerated, nationally organized plan to eliminate hepatitis C virus in the United States could save more than 90,000 lives and nearly $60 billion by 2050, according to a health economics expert at The Liver Meeting.

Rural and American Indian and Alaska Native populations face significant distance barriers to COVID-19 test-to-treat sites, a recent study in JAMA Open Network found.

Studies analyzing four molecular tests commonly used to assess malignancy in thyroid nodules have high sensitivity despite several limitations, according to findings from a systematic review and meta-analysis.

CHICAGO — In patients with thrombotic antiphospholipid syndrome, vitamin K antagonists were linked to lower odds of arterial thrombotic events compared with direct oral anticoagulants, according to a meta-analysis.